Genetic Technologies: Growing Pipeline of Next Generation Disease Risk Tests
Nov. 17, 2020
Genetic Technologies (NASDAQ: GENE) is a diversified molecular diagnostics company. GENE offers cancer predictive testing and assessment tools to help physicians proactively manage patient health. The Company's lead products GeneType for Breast Cancer for non-hereditary breast cancer and GeneType for Colorectal Cancer are clinically validated risk assessment tests and are first in class. Genetic Technologies is developing a pipeline of risk assessment products for COVID-19 and other diseases. Visit GENEtechinfo.com to learn more.
